Brief: India's Glenmark Life Sciences Dec-Quarter Profit Rises
Jan 27 (Reuters) - Glenmark Life Sciences Ltd GLEM.NS :
* DEC-QUARTER PROFIT 1.05 BILLION RUPEES VERSUS 1.04 BILLION
RUPEES
* DEC-QUARTER REVENUE FROM OPERATIONS 5.41 BILLION RUPEES
VERSUS
5.22 BILLION RUPEES
* REVIVING DEMAND IN REGULATED MARKETS, GPL BUSINESS WILL
PROPEL
GROWTH IN COMING QUARTERS
Source text for Eikon: ID:nBSE2Nk8vX
Further company coverage: GLEM.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees